SPC382

Dróspírenón ásamt estetróli

  • Status:
    Veitt
  • Application date:
    7.6.2022
  • Application published:
    15.7.2022
  • Grant published:
    15.10.2025
  • Max expiry date:
    19.5.2036
  • Medicine name:
    Drovelis; Lydisilka
  • Medicine for children:
    No

Timeline

Today
7.6.2022Application
15.7.2022Publication
15.10.2025Registration
19.5.2036Expires

Marketing license

  • IS authorization number:
    EU/1/21/1547/001-004; EU/1/21/1548/001-004
  • Date:
    8.6.2021
  • Foreign authorization number:
    EU/1/21/1547 & EU/1/21/1548
  • Date:
    19.5.2021

Owner

  • Name:
    Estetra SRL
  • Address:
    Rue Saint-Georges 5, Liege BE

Agent

  • Name:
    G.H. Sigurgeirsson ehf.
  • Address:
    Borgartúni 26, 105 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 08.10.2025

Upload documents